Agenda Highlights
The preliminary list of topics for this year’s conference includes:
- The Treatment of AMI: What Have We Learned in 50 Years?
- Do ACS Guidelines Change Clinical Practice?
- Clinical Trials: Why They Fail to Meet Expectations
- Heart Failure Lost and Found—Discoveries over 25 Years
– — –
- Newer Indications and Limitations of Statin Therapy
- Venous Thromboembolic Disease: Diagnosis and Treatment
- From Darwin to Tilt Table Testing: Pathophysiology and Management of Vasovagal Syncope
- Looking Forward: Are We Ready for Cardiovascular Vaccines?
– — –
- Atrial Fibrillation Is an Inflammatory Disease
- Pulmonary Vein Ablation for Atrial Fibrillation
- Surgical Treatment of Atrial Fibrillation
- Management of Atrial Fibrillation in Heart Failure
– — –
- Update on Infectious Endocarditis Prophylaxis
- Novel Anticoagulants: Goodbye, Warfarin!
- Targeting Inflammation As a Predictor of Risk
- Cardiovascular Risk in HIV and Inflammatory Diseases
– — –
- CABG vs. PCI for Left Main and Three-Vessel Coronary Artery Disease
- Coronary Artery Imaging: Is It Time for MRI?
- Antithrombotics in Post-PCI Care
– — –
- The Metabolic Syndrome: What Every Cardiologist Should Know
- Prognosis of Patients with ICDs
- Evaluation of Cardiac Masses
- New Cardiovascular Risk Scoring: The Reynolds Risk Score
Planning for the 2009 conference is underway, and the agenda is subject to change.
Pre-Conference Event: The 14th Annual Residents’ Research Competition
The annual competition is open to all cardiology residents and fellows in training programs in Canada. Each submission must be based upon work carried out within the three core years of cardiology training. Get complete competition information for the 2009 competition.
Prizes will be awarded, including transportation costs to Lake Louise, accommodation, and conference registration fees for four finalists. The winning resident/fellow will be recognized at the conference and invited to present her/his work before the entire conference assembly.
Email to a colleague







